Evidence map›Paper›PMID 39572679›Full record

ArticleCommunications biology2024

Endogenous mitochondrial NAD(P)H fluorescence can predict lifespan.

Christopher S Morrow, Pallas Yao, Carlos A Vergani-Junior, Praju Vikas Anekal, Paula Montero Llopis, Jeffrey W Miller, Bérénice A Benayoun, William B Mair

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Changes in the brain [NADFrontiers in aging neuroscience · 2026
    Review
  4. Article
  5. Efficacy Evaluation of "Enhanced" Natural Killers withSovremennye tekhnologii v meditsine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher S MorrowDepartment of Molecular Metabolism, Harvard TH Chan School of Public Health, Boston, MA, USA.
Pallas YaoDepartment of Molecular Metabolism, Harvard TH Chan School of Public Health, Boston, MA, USA.
Carlos A Vergani-JuniorDepartment of Molecular Metabolism, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-2595-7477
Praju Vikas AnekalMicRoN Core, Harvard Medical School, Boston, MA, USA.
Paula Montero LlopisMicRoN Core, Harvard Medical School, Boston, MA, USA.
Jeffrey W MillerDepartment of Biostatistics, Harvard University, Boston, MA, USA.
Bérénice A BenayounLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-7401-4777
William B MairDepartment of Molecular Metabolism, Harvard TH Chan School of Public Health, Boston, MA, USA. wmair@hsph.harvard.edu.ORCID 0000-0002-0661-1342

Funding

Mechanisms Specific to the Beneficial Effects of Dietary RestrictionR01AG044346 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI William B Mair · 2013 to 2026
$3.8M
Cell Non-autonomous Regulation of Aging via Neuronal TORC1R01AG059595 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI MAIR, WILLIAM B · 2018 to 2022
$2.0M
Reversing Loss of Metabolic Homeostasis to Ameliorate Alzheimer's Disease PathogenicityR01AG067106 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI MAIR, WILLIAM B · 2020 to 2024
$2.0M
Harnessing Redox Regulation of Proteasome Function to Promote Healthy AgingF32AG085703 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Christopher Scott Morrow · 2024 to 2026
$250k
NIA NIH HHS F32 AG085703NIA NIH HHS R01 AG044346NIA NIH HHS R01 AG059595NIA NIH HHS R01 AG067106U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) F32AG085703U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG044346U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG067106
6 · The paper itself

Abstract

Many aging clocks have recently been developed to predict health outcomes and deconvolve heterogeneity in aging. However, existing clocks are limited by technical constraints, such as low spatial resolution, long processing time, sample destruction, and a bias towards specific aging phenotypes. Therefore, here we present a non-destructive, label-free and subcellular resolution approach for quantifying aging through optically resolving age-dependent changes to the biophysical properties of NAD(P)H in mitochondria through fluorescence lifetime imaging (FLIM) of endogenous NAD(P)H fluorescence. We uncover age-dependent changes to mitochondrial NAD(P)H across tissues in C. elegans that are associated with a decline in physiological function and construct non-destructive, label-free and cellular resolution models for prediction of age, which we refer to as "mito-NAD(P)H age clocks." Mito-NAD(P)H age clocks can resolve heterogeneity in the rate of aging across individuals and predict remaining lifespan. Moreover, we spatiotemporally resolve age-dependent changes to mitochondria across and within tissues, revealing multiple modes of asynchrony in aging and show that longevity is associated with a ubiquitous attenuation of these changes. Our data present a high-resolution view of mitochondrial NAD(P)H across aging, providing insights that broaden our understanding of how mitochondria change during aging and approaches which expand the toolkit to quantify aging.

Indexed as

Caenorhabditis elegansLongevityMitochondriaNADPAgingAnimalsFluorescenceNADOptical ImagingNADNADP

Identifiers

PMID39572679
PMCPMC11582643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.